Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Former Indonesia Health Minister Testifies On Medical-Equipment Graft

This article was originally published in PharmAsia News

Executive Summary

Indonesia’s former health minister, Siti Fadillah Supari, has been called as a witness in a government probe into possible bribery involving purchases of medical equipment to deal with the 2006 bird-flu epidemic.

You may also be interested in...



CanSino Moving Coronavirus Vaccine To Phase III

CanSino plans to start a Phase III study soon for its candidate with a 40,000 enrollment target, discloses its co-founder.

UK’s CMA Doubles Down On Liothyronine Objections

The UK’s CMA has reiterated its belief that Advanz Pharma charged excessive and unfair prices for liothyronine in the UK, following a separate ruling that provided detailed guidance on how such matters should be evaluated.

UK Probiotics Distribution Deal Latest Milestone In OptiBiotix Growth Journey

UK probiotics specialist Optibiotix' CEO Stephen O'Hara speaks exclusively to HBW Insight about the firm's growth ambitions, which have not been held back by the coronavirus pandemic. 

Topics

UsernamePublicRestriction

Register

ID1131511

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel